Corporates Zydus Lifesciences’ Ankleshwar API unit clears USFDA inspection with zero… Aditya Bhagchandani Mar 15, 2025
Corporates Zydus Lifesciences to acquire 85.6% stake in Amplitude Surgical SA for Rs 2,442… Aman Shukla Mar 11, 2025
Corporates Zydus Lifesciences announces U.S. FDA priority review for CUTX-101, a potential… Aditya Bhagchandani Jan 7, 2025
Corporates Zydus Lifesciences receives USFDA approval for Lidocaine and Prilocaine Cream USP Aman Shukla Dec 19, 2024
Stock Market Zydus Lifesciences’s market cap gains Rs 1,363 crore as stock surges 1.43% Aditya Bhagchandani Nov 13, 2024
Corporates Zydus Lifesciences Q2 FY25: Revenue up 20% YoY to Rs 5237 crore, Net Profit up… Aditya Bhagchandani Nov 12, 2024
Stock Market Zydus Lifesciences receives WHO approval for ZyVac® TCV, making it eligible for UN… Aditya Bhagchandani Oct 23, 2024
Corporates Zydus Lifesciences gets USFDA approval to manufacture Fludrocortisone Acetate… Aman Shukla Oct 17, 2024
Stock Market Zydus Lifesciences shares decline nearly 3% after Exelixis wins patent ruling over… Aditya Bhagchandani Oct 16, 2024
Corporates Zydus Lifesciences gets tentative approval from USFDA for Enzalutamide Tablets, 40… Aman Shukla Oct 2, 2024
Stock Market BofA Securities cuts target prices for Zydus Life and Lupin shares amid Mirabegron… News Desk Sep 20, 2024
Corporates Zydus Lifesciences approves Rs 84 crore acquisition of Sterling Biotech’s API… Aman Shukla Sep 17, 2024
Corporates Zydus Lifesciences secures licensing and supply agreement for MRI contrast agents… Markets Desk Sep 13, 2024
Stock Market Stocks to Watch: Reliance, Zydus Lifesciences, ONGC in focus today (Sept 11, 2024) News Desk Sep 11, 2024
Corporates Zydus Lifesciences completes its Phase II(a) clinical trial of Usnoflast Aman Shukla Sep 10, 2024
Corporates Zydus Lifesciences gets warning letter from USFDA for injectables manufacturing… Aman Shukla Sep 3, 2024
Corporates Zydus Lifesciences gets warning letter from USFDA relating to its injectables… Aman Shukla Aug 30, 2024
